First patient enrolled in brain tumor trial combining 9 repurposed drugs - CUSP9v3 project This is the 3rd version of CUSP9... it appears that they are only taking patients from Germany at this time, however, since all of the treatments are already approved and readily available, it can be done outside of that trial. If you try it, please register for our virtual trial project first at virtualtrials.com. That way we can track results.
Some glioblastoma patients benefit from 'ineffective' treatment, Stanford researchers say This is the problem with clinical trials.. if the average patients doesn't benefit, they call it a failure. They do not identify the patients who do benefit. In this case, they identified a group of patients who would benefit from Avastin, even though an average patient doesn't. I have seen many patients with a huge benefit from it, which makes no sense when you look at the trial results. This may explain why. They should go back to the original Avastion trials, and see if this group of patients did better,
Novel Type of Immunotherapy Helps Man Fight Brain Cancer Of course it is too early to tell how it will work but great sign that they were able to get rid of all of the tumors for a while, and that they have shown it is safe to use multiple times.
